• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

EKR Therapeutics

edit

EKR Therapeutics, Inc., a specialty pharmaceutical company, focuses on acquiring, developing, and commercializing prescription products and oncology supportive care. It focuses on various areas, including oral mucositis, stomatitis, dry mouth/xerostomia, nutritional issues, cachexia, skin reactions, bone marrow depression, bone complications, acute and chronic pain, nausea, vomiting, and diarrhea. The company was founded in 2005 and is based in Bedminster, New Jersey.

Recent Milestones

edit

• 
  EKR Therapeutics was acquired by Cornerstone Therapeutics for $150M. (5/15/12)
  Posted 5/15/12 at 7:50pm via dowjones.com
• 
  EKR Therapeutics added John E. Bailye as President & CEO.
  Posted 10/14/11 at 6:14pm
• 
  EKR Therapeutics added Bill McKee as COO, CFO.
  Posted 10/14/11 at 6:14pm

Videos

Screenshots

edit

Sources

1. Cornerstone Thera to Acquire EKR Thera For $150M Cash, Milestones (pevc.dowjones.com) [edit]